CRNX — Crinetics Pharmaceuticals, Inc.

CRNXCrinetics Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · crinetics.com

36.62USD-0.49%Mkt Cap: 3.88B USDP/E: —Last update: 2026-05-26

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The c…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap3.88B USD

Enterprise Value2.67B USD

Revenue (TTM)18.07M USD

Gross Profit6.62M USD

Net Income (TTM)-465.32M USD

Revenue/Share0.1870 USD

Last Price36.62 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees594

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS22663K1079

Valuation

P/E (Trailing)—

P/E (Forward)-8.81

PEG—

EV/EBITDA-4.92

EV/Revenue147.62

P/S216.44

P/B3.05

EPS (TTM)-5.14

EPS (Forward)-4.21

52W Range

25.8334% of range57.99

52W High57.99 USD

52W Low25.83 USD

Profitability

Gross Margin86.02%

Oper. Margin-1307.79%

EBITDA Margin0.00%

Profit Margin-6046.22%

ROE-46.90%

ROA-41.32%

Growth

Revenue Growth2873.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF-377.92M USD

CapEx (TTM)5.76M USD

FCF Margin-1340.06%

FCF Yield-6.25%

Net Debt-1.24B USD

Net Debt/EBITDA2.30

Balance Sheet

Debt/Equity0.05

Current Ratio18.60

Quick Ratio18.25

Book Value/Sh12.16 USD

Cash/Share12.25 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)83.14 USD

Target Range55.00 USD – 97.00 USD

# Analysts14

Ownership

Shares Out.105.44M

Float95.58M

Insiders1.59%

Institutions120.09%

Short Interest

Short Ratio13.0d

Short % Float15.74%

Short % Out.13.44%

Shares Short14.17M

Short (prev mo.)16.06M

Technical

SMA 5037.83 (-3.2%)

SMA 20041.25 (-11.2%)

Beta0.28

S&P 52W Chg28.31%

Avg Vol (30d)1.21M

Avg Vol (10d)1.47M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—